In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Total revenues [+] | 42.3 | 4.5 | 22.6 | 7.3 | 7.3 | 0.0 | 0.0 |
Royalties | | | | | | 17.9 | 17.1 |
License and services | | | | 7.3 | | | |
Revenue growth | 832.4% | -79.9% | 209.4% | 0.0% | | | |
Cost of goods sold | 1.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 41.2 | 4.5 | 22.6 | 7.3 | 7.3 | 0.0 | 0.0 |
Gross margin | 97.2% | 100.0% | 100.0% | 100.0% | 100.0% | | |
Selling, general and administrative [+] | 172.6 | 71.9 | 30.0 | 17.7 | 8.3 | 4.4 | 3.1 |
General and administrative | | | | 17.7 | 8.3 | 4.4 | 3.1 |
Research and development | 80.5 | 104.4 | 83.2 | 66.8 | 30.7 | 17.9 | 17.1 |
EBITDA [+] | -211.4 | -171.4 | -90.5 | -77.2 | -31.6 | -22.3 | -20.2 |
EBITDA growth | 23.3% | 89.4% | 17.3% | 144.0% | 42.0% | 10.4% | |
EBITDA margin | -499.3% | -3775.2% | -400.7% | -1057.3% | -433.3% | | |
Depreciation and amortization | 0.6 | 0.3 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
EBIT [+] | -212.0 | -171.8 | -90.6 | -77.3 | -31.7 | -22.3 | -20.2 |
EBIT growth | 23.4% | 89.5% | 17.3% | 143.7% | 42.1% | 10.4% | |
EBIT margin | -500.6% | -3782.7% | -401.3% | -1058.2% | -434.2% | | |
Non-recurring items [+] | 2.0 | 128.6 | | 2.4 | | | |
Asset impairment | 1.1 | | | 2.4 | | | |
In-process research & development | 0.9 | 128.6 | | | | | |
Interest expense, net [+] | 15.6 | 8.1 | | 0.1 | 0.1 | 0.0 | |
Interest expense | 15.6 | 8.1 | | 0.1 | 0.2 | 0.0 | 0.1 |
Interest income | | | | | 0.0 | | 0.1 |
Other income (expense), net [+] | 7.9 | 5.2 | 1.5 | 0.8 | | 0.0 | -0.1 |
Gain (loss) on debt retirement | | | | -0.1 | | | |
Pre-tax income | -221.7 | -303.3 | -89.1 | -79.0 | -31.8 | -22.4 | -20.3 |
Income taxes | -0.2 | 0.0 | 0.0 | -0.6 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.1% | 0.0% | 0.0% | 0.8% | | 0.0% | 0.0% |
Net income | -221.5 | -303.3 | -89.1 | -78.4 | -31.9 | -22.4 | -20.3 |
Net margin | -523.3% | -6678.3% | -394.4% | -1074.0% | -436.6% | | |
|
Basic EPS [+] | ($5.27) | ($7.48) | ($2.70) | ($2.93) | ($4.96) | ($27.03) | ($27.99) |
Growth | -29.5% | 177.3% | -8.1% | -40.9% | -81.7% | -3.4% | |
Diluted EPS [+] | ($5.27) | ($7.48) | ($2.70) | ($2.93) | ($4.96) | ($27.03) | ($27.99) |
Growth | -29.5% | 177.3% | -8.1% | -40.9% | -81.7% | -3.4% | |
|
Shares outstanding (basic) [+] | 42.0 | 40.6 | 33.0 | 26.7 | 6.4 | 0.8 | 0.7 |
Growth | 3.6% | 22.7% | 23.6% | 315.9% | 677.3% | 14.3% | |
Shares outstanding (diluted) [+] | 42.0 | 40.6 | 33.0 | 26.7 | 6.4 | 0.8 | 0.7 |
Growth | 3.6% | 22.7% | 23.6% | 315.9% | 677.3% | 14.3% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |